Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) FCF Margin (2019 - 2025)

Historic FCF Margin for aTYR PHARMA (ATYR) over the last 6 years, with Q3 2025 value amounting to 10796.32%.

  • aTYR PHARMA's FCF Margin changed N/A to 10796.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 33154.21%, marking a year-over-year decrease of 45984700.0%. This contributed to the annual value of 29440.0% for FY2024, which is 188349000.0% down from last year.
  • Latest data reveals that aTYR PHARMA reported FCF Margin of 10796.32% as of Q3 2025.
  • Over the past 5 years, aTYR PHARMA's FCF Margin peaked at 110.61% during Q4 2022, and registered a low of 10796.32% during Q3 2025.
  • For the 4-year period, aTYR PHARMA's FCF Margin averaged around 5825.82%, with its median value being 6198.18% (2023).